India, Sept. 7 -- The Bengaluru-headquartered pharma exporter has had a good few weeks. Strides Pharma Science shares pushed higher again this week, continuing a run that kicked off once a key US regulatory hurdle at its main manufacturing site got cleared. There's more than one thing driving it, though better compliance standing, a stronger-than-expected quarterly report, and steady growth in markets beyond the US all seem to be playing a part. Whether the rally holds is still an open question, but the numbers underneath it aren't thin.

Shares of Strides Pharma Science Ltd are trading at Rs. 1,166.00, up 10.04 percent on Monday. The stock touched the intraday high of Rs. 1,187.60 after opening at Rs. 1,058.70 before slipping to a low of...